Facebook: World Allergy Organization
Twitter: World Allergy Organization
LinkedIn: World Allergy Organization
Instagram: World Allergy Organization
Back to Top

Richard F. Lockey, MD, MS

Richard F. Lockey, MD, MS, is a Distinguished University Health Professor; Professor of Medicine, Pediatrics and Public Health; Joy McCann Culverhouse Chair of Allergy/Immunology (A/I) and Director, Division of A/I, Department of Internal Medicine (IM), University of South Florida College of Medicine, and James A. Haley Veterans’ Hospital, Tampa, Florida.

He received a B.S. degree from Haverford College, Haverford, Pennsylvania; M.D. from Temple University, Philadelphia, Pennsylvania (Alpha Omega Alpha); M.S. from the University of Michigan in Ann Arbor, Michigan where he trained in A/I and was a Major and Chief of A/I at Carswell Air Force Base, Fort Worth, Texas, 1970-1972. 

He has the honor of authoring, co-authoring or editing over 600 publications and 35 books or monographs with colleagues and has lectured on numerous occasions nationally and internationally. Professional honors include President of the American Academy of Allergy Asthma and Immunology (1992), past Director of the American Board of Allergy and Immunology (1993-1998) and President of the World Allergy Organization (2010-2012).  He has served as co-editor or participant of two WHO reports, served on many journal editorial boards and has been honored for his research and contributions to medicine and the specialty. 

Over 90 physician specialists and 50 international post-graduate PhDs or MDs in basic and clinical research and medicine, many of whom have assumed leadership positions in medicine throughout the world, have been trained in the Division. 

The Division, its Joy McCann Culverhouse Airway Disease Research Center and Clinical Research Unit core faculty is staffed by 3 basic, 6 clinical scientists, and approximately 60 other physicians and healthcare professional.

Areas of Expertise and Research: Insect Allergy; Allergen Immunotherapy; Asthma; Inflammatory Lung Diseases; Pulmonary Fibrosis; Co-morbid Conditions of Asthma; and RSV Vaccine Development.